Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy [Phase 3]

View source ↗

Summary

A phase 3 clinical trial update describes monoclonal antibody therapy for patients with ovarian cancer or primary peritoneal cancer in remission after surgery a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Monoclonal antibody therapy

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | Status: UNKNOWN